{
    "2019-01-16": [
        [
            {
                "time": "",
                "original_text": "药明康德：受益于创新药研发的CRO龙头",
                "features": {
                    "keywords": [
                        "药明康德",
                        "创新药",
                        "CRO",
                        "龙头"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成将登陆A股：药明康德竞争对手机未来前景如何",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "A股",
                        "药明康德",
                        "竞争对手机",
                        "未来前景"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}